ANIP
ANIP
NASDAQ · Pharmaceuticals

Ani Pharmaceuticals Inc

$67.79
-1.83 (-2.63%)
As of Nov 7, 1:43 AM ET ·
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 12 80%
Hold 3 20%
Sell 0 0%
Price Target
Analyst Price Target -45.8% upside
Low Target $28.36
Average Target $36.71
High Target $54.52
Current Price $67.79
Current
$67.79
Target
$36.71
$28.36 $36.71 avg $54.52
Scenario Analysis
Bear Case
$28.36
-58.2%
Low target
Base Case
$36.71
-45.8%
Avg target
Bull Case
$54.52
+-19.6%
High target
Risk/Reward
0.3x
Unfavorable
Price in Context
52-Week High
$95.57
-29.1% from high
52-Week Low
$68.79
+-1.4% from low
Target vs 52W High
$36.71
-61.6% vs high
Next Earnings Report
Nov 11, 2026
3d
until earnings
EPS Est: $2.22
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 36 86% $1,330.33 -1.7%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 73% $299.55 +8.4%
MRK
Merck & Co. Inc.
Buy 35 74% $159.27 +8.5%
PFE
Pfizer Inc.
Hold 33 39% $33.90 +15.3%
BMY
Bristol-Myers Squibb Co
Hold 34 44% $174.50 +180.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.1%
ZTS
Zoetis Inc
Hold 23 48% $209.87 +164.3%